Congressional disclosures
Andrew R. Garbarino
Recent disclosures
16 of 16 on record · Apr 23, 2021 to Aug 21, 2025| Asset | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| GAPGAP, INC. | Stock | Sale | $1,001 - $15,000 | +0.8%S&P +20.0% · vs S&P 500 -19.2% | Aug 21, 2025 | Aug 21, 2025 | 0d |
| TELLTELLURIAN INC.Energy | Stock | Purchase | $1,001 - $15,000 | -68.6%S&P +23.3% · vs S&P 500 -91.9% | Jan 14, 2022 | Jan 14, 2022 | 0d |
| ORMPORAMED PHARMACEUTICALS INC.Healthcare | Stock | Sale | $1,001 - $15,000 | -56.7%S&P +64.1% · vs S&P 500 -120.8% | Jan 14, 2022 | Jan 14, 2022 | 0d |
| OSWONESPAWORLD HOLDINGS LIMITED - COMMON SHARESConsumer Cyclical | Stock | Sale | $1,001 - $15,000 | +116.1%S&P +75.6% · vs S&P 500 +40.5% | Oct 1, 2021 | Nov 3, 2021 | 33d |
| TELLTELLURIAN INC.Energy | Stock | Purchase | $1,001 - $15,000 | -74.8%S&P +32.0% · vs S&P 500 -106.8% | Oct 1, 2021 | Nov 3, 2021 | 33d |
| GPSConsumer Cyclical | Stock | Purchase | $1,001 - $15,000 | +4.2%S&P +29.1% · vs S&P 500 -24.9% | Oct 1, 2021 | Nov 3, 2021 | 33d |
| ORMPORAMED PHARMACEUTICALS INC.Healthcare | Stock | Sale | $1,001 - $15,000 | -77.2%S&P +75.6% · vs S&P 500 -152.8% | Oct 1, 2021 | Nov 3, 2021 | 33d |
| VMCCXAs filed: PURCHASE OF MUTUAL FUND | Other | Purchase | $1,001 - $15,000 | n/a | Jun 7, 2021 | Jul 9, 2021 | 32d |
| NEW WORLD NEWFXAs filed: SALE OF MUTUAL FUND | Other | Sale | $1,001 - $15,000 | n/a | Jun 3, 2021 | Jul 9, 2021 | 36d |
| INVESTMENT COMPANY OF AMERICA AIVSXAs filed: SALE OF MUTUAL | Other | Sale | $1,001 - $15,000 | n/a | Jun 3, 2021 | Jul 9, 2021 | 36d |
| NEW PERSPECTIVE ANWPXAs filed: SALE OF MUTUAL FUND | Other | Sale | $1,001 - $15,000 | n/a | Jun 3, 2021 | Jul 9, 2021 | 36d |
| CAPITAL WORLD GROW AND INCOMEAs filed: SALE OF MUTUAL FUND | Other | Sale | $1,001 - $15,000 | n/a | Jun 3, 2021 | Jul 9, 2021 | 36d |
| OSWONESPAWORLD HOLDINGS LIMITED - COMMON SHARESConsumer Cyclical | Stock | Purchase | $1,001 - $15,000 | +118.4%S&P +83.0% · vs S&P 500 +35.5% | Apr 23, 2021 | May 24, 2021 | 31d |
| ORMPORAMED PHARMACEUTICALS INC.Healthcare | Stock | Purchase | $1,001 - $15,000 | -51.1%S&P +83.0% · vs S&P 500 -134.1% | Apr 23, 2021 | May 24, 2021 | 31d |
| GSSGOLDEN STAR RESOURCES, LTDBasic Materials | Stock | Sale | $1,001 - $15,000 | +6.3%S&P +3.5% · vs S&P 500 +2.7% | Apr 23, 2021 | May 24, 2021 | 31d |
| BACFinancial Services | Stock | Sale | $1,001 - $15,000 | +60.0%S&P +83.0% · vs S&P 500 -23.0% | Apr 23, 2021 | May 24, 2021 | 31d |
No disclosures of that kind among the 16 rows shown.
Showing the 16 most recent disclosures. One row is one disclosure: a member filing for more than one account on the same day, in the same band, is counted once and marked.
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, with the S&P 500 over the same window and the difference against it. The numbers describe the stock after the trade, not the member's result: a disclosure carries a band, not a fill, and a sale keeps the same sign, so a positive number after a sale means the stock kept rising. An option row carries the underlying stock's move. Estimates; n/a on assets with no market price. Not investment advice.
Estimated portfolio
4 holdings · $15,001 - $50,000 in total · estimate, as of Sep 10, 2026| Holding | Estimated value | Share of portfolio |
|---|---|---|
| BMY | $1,001 - $15,000 | |
| ROP | $1,001 - $15,000 | |
| ZTS | $1,001 - $15,000 | |
| INTC | $1,001 - $15,000 |
The 4 largest of 4 estimated holdings. Every figure is an estimate built from the disclosed ranges, marked by the price movement of each stock since the filing; the share is of the whole estimated portfolio, small positions included.
Year by year
buy volume against sale volume · range midpointsDisclosed volume per year the member traded, 2021 to 2025. A filing gives a range, not an amount, so each bar sums the midpoints of the ranges disclosed that year: a $1,001 to $15,000 line counts as $8,000.
Where the disclosed portfolio sits
by weightGetSignal pushes each new disclosure to your phone as it lands, with the full history and every other member. Free on iOS and Android.
Questions
How many stock trades has Andrew R. Garbarino disclosed?
Andrew R. Garbarino has disclosed 16 transactions under the STOCK Act. This page lists the 16 most recent, covering Apr 23, 2021 to Aug 21, 2025.
How long does Andrew R. Garbarino take to report a trade?
Across the disclosures shown here the median gap between the transaction and its publication is 33 days. The STOCK Act allows up to 45, so a delay inside that window is lawful.
Which stocks does Andrew R. Garbarino trade most?
In the disclosures shown here the most frequent tickers are ORMP, OSW, TELL, BAC, GAP.
Where does the estimated net worth on this page come from?
It is an estimate produced by a model, not a figure the member disclosed. Congressional financial disclosure reports every asset and liability in a band rather than an amount, so the model takes a value within each band and nets the liabilities, and it carries the stock holdings it tracks at the latest price we hold, which is why the estimate can move on a day when nothing was filed. It is shown to two figures because the largest band is open ended and a third would be arithmetic rather than information. It covers only what the disclosures carry, and it is not a measurement of anyone's wealth. The methodology page sets out how it is built and what it leaves out.
How have the stocks moved since Andrew R. Garbarino's trades?
Across the 11 priced rows shown, the median stock move from the trade date to the latest close we hold (Sep 10, 2026) is +0.8%. That figure is an estimate describing the stock after each trade, not the member's result: a disclosure carries a band, not a fill, a sale keeps the same sign, and an option row carries the underlying stock's move. 5 of the rows shown have no market price.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
A disclosure is a record of a transaction, not evidence of anything else, and nothing here is investment advice. Sourcing and the limits of this data are on the methodology page.
Data as of Sep 10, 2026.